1. Home
  2. ABAT vs STRO Comparison

ABAT vs STRO Comparison

Compare ABAT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Battery Technology Company

ABAT

American Battery Technology Company

HOLD

Current Price

$3.09

Market Cap

517.0M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$26.12

Market Cap

524.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABAT
STRO
Founded
2011
2003
Country
United States
United States
Employees
N/A
133
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
517.0M
524.8M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ABAT
STRO
Price
$3.09
$26.12
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$6.00
$31.33
AVG Volume (30 Days)
5.9M
305.5K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
43.14
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$145.40
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$0.67
52 Week High
$11.49
$43.85

Technical Indicators

Market Signals
Indicator
ABAT
STRO
Relative Strength Index (RSI) 43.45 40.48
Support Level $2.35 $23.43
Resistance Level $3.67 $27.96
Average True Range (ATR) 0.30 3.16
MACD 0.00 -0.73
Stochastic Oscillator 24.59 17.09

Price Performance

Historical Comparison
ABAT
STRO

About ABAT American Battery Technology Company

American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: